Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasia-Maria Zavitsanou

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Trends in Cell Biology|May 26, 2021
Hunger brings down the tumor fortAnastasia-Maria Zavitsanou, Thales Papagiannakopoulos
Cancer Discovery|February 1, 2022
NRF2: KEAPing Tumors ProtectedRay Pillai, Makiko Hayashi, Anastasia-Maria Zavitsanou, et al.
Nature Communications|January 28, 2017
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinomaSam Sheppard, Joana Guedes, Anna Mroz, et al.
Cell Reports Methods|February 14, 2026
HazardPyMatch: A tool for identifying reproductive and other hazards in scientific laboratoriesEmily M Parker, Anastasia-Maria Zavitsanou, Clara Liff, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
HazardPyMatch: A Tool for identifying reproductive and other hazards in scientific laboratoriesEmily M Parker, Anastasia-Maria Zavitsanou, Clara Liff, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Temporal Tracking of Plasma Cells <i>in vivo</i> Using J-chain CreERT2 Reporter SystemTimothy C Borbet, Kimberly Zaldaña, Anastasia-Maria Zavitsanou, et al.
Elife|October 3, 2017
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancerVolkan I Sayin, Sarah E LeBoeuf, Simranjit X Singh, et al.
Annals of the New York Academy of Sciences|November 13, 2020
Frontiers in cancer immunotherapy-a symposium reportJennifer Cable, Benjamin Greenbaum, Dana Pe'er, et al.
Cancer Discovery|August 4, 2021
Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung CancerMetamia Ciampricotti, Triantafyllia Karakousi, Allison L Richards, et al.
Cell Reports|October 27, 2023
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistanceAnastasia-Maria Zavitsanou, Ray Pillai, Yuan Hao, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Trends in Cell Biology|May 26, 2021
Hunger brings down the tumor fortAnastasia-Maria Zavitsanou, Thales Papagiannakopoulos
Cancer Discovery|February 1, 2022
NRF2: KEAPing Tumors ProtectedRay Pillai, Makiko Hayashi, Anastasia-Maria Zavitsanou, et al.
Nature Communications|January 28, 2017
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinomaSam Sheppard, Joana Guedes, Anna Mroz, et al.
Cell Reports Methods|February 14, 2026
HazardPyMatch: A tool for identifying reproductive and other hazards in scientific laboratoriesEmily M Parker, Anastasia-Maria Zavitsanou, Clara Liff, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
HazardPyMatch: A Tool for identifying reproductive and other hazards in scientific laboratoriesEmily M Parker, Anastasia-Maria Zavitsanou, Clara Liff, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Temporal Tracking of Plasma Cells <i>in vivo</i> Using J-chain CreERT2 Reporter SystemTimothy C Borbet, Kimberly Zaldaña, Anastasia-Maria Zavitsanou, et al.
Elife|October 3, 2017
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancerVolkan I Sayin, Sarah E LeBoeuf, Simranjit X Singh, et al.
Annals of the New York Academy of Sciences|November 13, 2020
Frontiers in cancer immunotherapy-a symposium reportJennifer Cable, Benjamin Greenbaum, Dana Pe'er, et al.
Cancer Discovery|August 4, 2021
Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung CancerMetamia Ciampricotti, Triantafyllia Karakousi, Allison L Richards, et al.
Cell Reports|October 27, 2023
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistanceAnastasia-Maria Zavitsanou, Ray Pillai, Yuan Hao, et al.
Pageof 2